Physician profile
Lloyd E Robinson
NPI 1265534184
$4,918.32
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $1,296 · 2021: $1,489 · 2022: $810 · 2023: $745 · 2024: $46.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,161.55 | 2019-2023 | |
| Amarin Pharma, INC. | $635.35 | 2020-2022 | |
| Lilly USA, LLC | $497.23 | 2020-2023 | Mounjaro, Jardiance, Trulicity |
| Merck Sharp & Dohme LLC | $473.45 | 2019-2022 | |
| Abbvie INC. | $415.38 | 2021-2023 | Linzess, Ubrelvy, Creon |
| Astrazeneca Pharmaceuticals Lp | $379.49 | 2019-2024 | Farxiga, Airsupra |
| Abbott Laboratories | $257.94 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $209.30 | 2020-2023 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.92 | 2021-2023 | Synjardy |
| Amgen INC. | $190.98 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.96 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $83.17 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $81.95 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.65 | 2020 | |
| Pfizer INC. | $44.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $34.89 | 2019-2020 | |
| Eisai INC. | $18.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.29 | 2020 | |
| Breg, INC | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.